Aspiriant LLC’s Synopsys SNPS Stock Holding History

Aspiriant LLC’s Portfolio SNPS Stock Details SNPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-32,409	Closed	-$2.77M	–	256
2018 Q2	$2.77M	Buy	+32,409	New	+$2.82M	0.24%	65

Other funds holding SNPS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Aspiriant LLC's SNPS Position: Q3 2018 in Review

Aspiriant LLC sold out of Synopsys (SNPS) in Q3 2018, closing a stake of 32,409 shares — an estimated $2.77M sold.

Aspiriant LLC first reported a position in SNPS in Q2 2018 and held it in 1 quarter. The position peaked at $2.77M in Q2 2018. 541 funds tracked by Wall St. Rank hold SNPS as of Q3 2018.

Aspiriant LLC reported no remaining Synopsys position as of Q3 2018 after selling out during the quarter.
Aspiriant LLC sold 32,409 Synopsys shares in Q3 2018, an estimated $2.77M.
Aspiriant LLC first reported a position in Synopsys in Q2 2018 and held it in 1 quarter.
Aspiriant LLC's Synopsys position peaked at $2.77M in Q2 2018.
541 funds tracked by Wall St. Rank held Synopsys as of Q3 2018.

Based on Aspiriant LLC's 13F filing for Q3 2018, filed 26 Oct 2018.